Filed: 5/15/2023ACC: 0001387131-23-006541
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 70 equity positions with a total reported market value of $303.01M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
70
Positions
$303.01M
Total AUM (reported)
47.88M
Total Shares
Allocation by class
COM$205.12M67.7%
SPONSORED ADR$28.92M9.5%
COM NEW$19.89M6.6%
TR UNIT$18.42M6.1%
NOTE 2.500% 3/1$7.41M2.4%
NOTE 2.250% 2/0$7.12M2.4%
COMMON STOCK$6.25M2.1%
Portfolio Concentration
Top 3$63.55M21.0%
4–10$80.36M26.5%
11–25$93.48M30.9%
Rest$65.62M21.7%
Top 3 weight
21.0%
Top 10 weight
47.5%
Voting Authority Distribution
Total shares with voting rights: 47.88M
Sole
Full voting authority
47.88M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole70
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings70
Rows:
CHINOOK THERAPEUTICS INC
SOLEShares976.02K
TypeSH
Market value$22.59M
7.46%
Sole
976.02K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares93K
TypeSH
Market value$22.53M
7.44%
Sole
93K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TRTR UNIT
SOLEShares45K
TypeSH
Market value$18.42M
6.08%
Sole
45K
Shared
0.00
None
0.00
PROMETHEUS BIOSCIENCES INC
SOLEShares150K
TypeSH
Market value$16.10M
5.31%
Sole
150K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares120K
TypeSH
Market value$12.77M
4.21%
Sole
120K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares716.15K
TypeSH
Market value$11.92M
3.94%
Sole
716.15K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares709.80K
TypeSH
Market value$11.77M
3.88%
Sole
709.80K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.08M
TypeSH
Market value$9.44M
3.12%
Sole
1.08M
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares380K
TypeSH
Market value$9.27M
3.06%
Sole
380K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares452.82K
TypeSH
Market value$9.09M
3.00%
Sole
452.82K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares260.01K
TypeSH
Market value$8.71M
2.87%
Sole
260.01K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares221.46K
TypeSH
Market value$7.79M
2.57%
Sole
221.46K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares113.22K
TypeSH
Market value$7.67M
2.53%
Sole
113.22K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares110K
TypeSH
Market value$7.64M
2.52%
Sole
110K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares10M
TypePRN
Market value$7.41M
2.45%
Sole
10M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares11M
TypePRN
Market value$7.12M
2.35%
Sole
11M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares529.37K
TypeSH
Market value$7.04M
2.32%
Sole
529.37K
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares881.33K
TypeSH
Market value$6.35M
2.09%
Sole
881.33K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares202.83K
TypeSH
Market value$6.25M
2.06%
Sole
202.83K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares35K
TypeSH
Market value$5.38M
1.77%
Sole
35K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares135.86K
TypeSH
Market value$5.11M
1.69%
Sole
135.86K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares357.29K
TypeSH
Market value$4.37M
1.44%
Sole
357.29K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares751.80K
TypeSH
Market value$4.31M
1.42%
Sole
751.80K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares40K
TypeSH
Market value$4.29M
1.42%
Sole
40K
Shared
0.00
None
0.00
SEAGEN INC
SOLEShares20K
TypeSH
Market value$4.05M
1.34%
Sole
20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CHINOOK THERAPEUTICS INCSOLE | COM | 976.02K | SH | $22.59M 7.46% | 976.02K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 93K | SH | $22.53M 7.44% | 93K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRTR UNITSOLE | TR UNIT | 45K | SH | $18.42M 6.08% | 45K | 0.00 | 0.00 |
PROMETHEUS BIOSCIENCES INCSOLE | COM | 150K | SH | $16.10M 5.31% | 150K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 120K | SH | $12.77M 4.21% | 120K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 716.15K | SH | $11.92M 3.94% | 716.15K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 709.80K | SH | $11.77M 3.88% | 709.80K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.08M | SH | $9.44M 3.12% | 1.08M | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 380K | SH | $9.27M 3.06% | 380K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADR | 452.82K | SH | $9.09M 3.00% | 452.82K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 260.01K | SH | $8.71M 2.87% | 260.01K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 221.46K | SH | $7.79M 2.57% | 221.46K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 113.22K | SH | $7.67M 2.53% | 113.22K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 110K | SH | $7.64M 2.52% | 110K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 10M | PRN | $7.41M 2.45% | 10M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.250% 2/0 | 11M | PRN | $7.12M 2.35% | 11M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 529.37K | SH | $7.04M 2.32% | 529.37K | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 881.33K | SH | $6.35M 2.09% | 881.33K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 202.83K | SH | $6.25M 2.06% | 202.83K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 35K | SH | $5.38M 1.77% | 35K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 135.86K | SH | $5.11M 1.69% | 135.86K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 357.29K | SH | $4.37M 1.44% | 357.29K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 751.80K | SH | $4.31M 1.42% | 751.80K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 40K | SH | $4.29M 1.42% | 40K | 0.00 | 0.00 |
SEAGEN INCSOLE | COM | 20K | SH | $4.05M 1.34% | 20K | 0.00 | 0.00 |
Page 1 of 3